Estrogen plus Progestin reduces the risk of fractures regardless of risk factors: The Women's Health Initiative.

被引：0
|
作者：
Watts, NB [1 ]
Robbins, J [1 ]
Chen, Z [1 ]
Cummings, SR [1 ]
Jackson, R [1 ]
LaCroix, A [1 ]
LeBoff, M [1 ]
Lewis, CE [1 ]
McGowan, J [1 ]
Neuner, J [1 ]
Pettinger, J [1 ]
Stefanick, M [1 ]
Wactawski-Wende, J [1 ]
Cauley, JA [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] Fracture risk after estrogen plus progestin discontinuation: The women's health initiative.
    Jackson, RD
    Watts, NB
    Caralis, P
    Cauley, JA
    Chen, Z
    Greep, N
    LaCroix, AZ
    Lewis, CE
    Mouton, CP
    Neuner, JM
    O'Sullivan, MJ
    Robbins, JA
    Sato, A
    Stefanick, ML
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S27 - S27
  • [2] Estrogen plus progestin and the risk of peripheral arterial disease - The Women's Health Initiative
    Hsia, J
    Criqui, MH
    Rodabough, RJ
    Langer, RD
    Resnick, HE
    Phillips, LS
    Allison, M
    Bonds, DE
    Masaki, K
    Caralis, P
    Kotchen, JM
    CIRCULATION, 2004, 109 (05) : 620 - 626
  • [3] Breast cancer after stopping estrogen plus progestin in postmenopausal women in the women's health initiative.
    Chlebowski, R. T.
    Kuller, L.
    Anderson, G.
    Mason, J. A.
    Schenken, R.
    Rajkovic, A.
    Stefanick, M.
    Sarto, G.
    Ravdin, P.
    Prentice, R.
    CANCER RESEARCH, 2009, 69 (02) : 78S - 79S
  • [4] Effect of estrogen plus progestin on stroke in the women's health initiative
    Wassertheil-Smoller, S
    Hendrix, S
    Heiss, G
    Limacher, M
    STROKE, 2003, 34 (01) : 244 - 244
  • [5] Prior hormone therapy and breast cancer risk in the Women's Health initiative randomized trial of estrogen plus progestin
    Anderson, Garnet L.
    Chlebowski, Rowan T.
    Rossouw, Jacques E.
    Rodabough, Rebecca J.
    McTiernan, Anne
    Margolis, Karen L.
    Aggerwal, Anita
    Curb, J. David
    Hendrix, Susan L.
    Hubbell, F. Allan
    Khandekar, Jamardan
    Lane, Dorothy S.
    Lasser, Norman
    Lopez, Ana Maria
    Potter, JoNell
    Ritenbaugh, Cheryl
    MATURITAS, 2006, 55 (02) : 103 - 115
  • [6] Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial
    Cauley, JA
    Robbins, J
    Chen, Z
    Cummings, SR
    Jackson, RD
    LaCroix, AZ
    LeBoff, M
    Lewis, CE
    McGowan, J
    Neuner, J
    Pettinger, M
    Stefanick, ML
    Wactawski-Wende, J
    Watts, NB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13): : 1729 - 1738
  • [7] Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials
    Crandall, Carolyn J.
    Aragaki, Aaron K.
    Cauley, Jane A.
    McTiernan, Anne
    Manson, JoAnn E.
    Anderson, Garnet
    Chlebowski, Rowan T.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) : 275 - 285
  • [8] Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials
    Carolyn J. Crandall
    Aaron K. Aragaki
    Jane A. Cauley
    Anne McTiernan
    JoAnn E. Manson
    Garnet Anderson
    Rowan T. Chlebowski
    Breast Cancer Research and Treatment, 2012, 132 : 275 - 285
  • [9] Estrogen plus progestin, benefits and risks: The "women's health initiative" trials
    Keller, KB
    Lemberg, L
    AMERICAN JOURNAL OF CRITICAL CARE, 2005, 14 (02) : 157 - 160
  • [10] Hypertension and stroke in the estrogen plus progestin trial of the Women's Health Initiative
    Wassertheil-Smoller, S
    Heiss, G
    Limacher, M
    Hendrix, S
    CIRCULATION, 2003, 107 (07) : E7007 - E7007
12345